ACHC at a glance
Acadia Healthcare Company Inc (ACHC, SEC CIK 1520697) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as July 27, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Acadia Healthcare Company Inc (ACHC) reported revenue of $3.3 billion (up 5.0% from FY2024) and a net loss of $1.1 billion. Diluted EPS was -$12.16.
- As of September 30, 2026, 32 institutional investment managers tracked by SignalX reported holding Acadia Healthcare Company Inc (ACHC) shares worth $1.4 billion in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $3.3B
- +5.0% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 32 funds
- $1.4B · −1 vs prior quarter
- Latest 8-K
- Nov 4, 2026
- Item 2.02 · Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material changes to 2025 Form 10-K risk factors disclosed
- Carried-forward risk: additional unknown risks could materially adversely affect business, financial condition, results, or cash flows
Management Discussion & Analysis
- Q3 revenue $895.3M, up 5.1% YoY from $851.6M, driven by same-facility revenue growth of 5.2%
- Net income $38.7M, 4.3% margin vs 4.5% YoY; effective tax rate 31.6% vs 4.2%
- Same-facility admissions grew 6.6%, while average length of stay declined 5.1%
- Operating cash flow $321.5M vs $218.2M; capital expenditures $165.9M, including $94.8M expansion spending
- Cash $163.3M vs $133.2M; Medicaid reforms may pressure reimbursement, though management expects exemptions to limit near-term impact
AI summary of the ACHC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q3 2026 operating and financial results announced for the quarter ended September 30, 2026
- Full results and management commentary available in Exhibit 99.1 press release
Item 7.01: Regulation FD Disclosure
- Third-quarter 2026 results conference call scheduled for November 5, 2026 at 9:00 a.m. Eastern Time
- Investor slides in Exhibit 99.2 may contain operating and financial details not included in this section
Item EX-99.1: Item EX-99.1
- Q3 revenue $895.3M, up 5.1%, with same-facility revenue up 5.2% on 1.1% higher patient days and 4.0% pricing growth
- Adjusted EBITDA $176.4M, up 2%, but adjusted EPS fell 17% to $0.60 as reported net income declined 5% to $34.5M
Item 8.01: Other Events
- Court preliminary approval of settlement resolving stockholder derivative claims against individual defendants
- Settlement covers four derivative actions tied to securities litigation settled in November 2025
Item 2.02: Results of Operations and Financial Condition
- Press release announces Acadia Healthcare’s second-quarter fiscal 2026 operating and financial results
- Reporting period ended June 30, 2026
Item 7.01: Regulation FD Disclosure
- Conference call scheduled for Q2 2026 results on July 29, 2026 at 9:00 a.m. Eastern Time
- Exhibit 99.2 slides may contain supplemental operating and financial information for investors
Item EX-99.1: Item EX-99.1
- Q2 revenue $865.8M, approximately flat, but normalized growth 2.8% after supplemental-payment timing
- Reported EPS $0.12 vs $0.33, while Adjusted EPS $0.38 vs $0.83, reflecting significant earnings pressure
AI summaries of ACHC 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for ACHC
Don't miss the next ACHC filing
- Alerts as it files. A push when ACHC files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut ACHC, by share count.
- Ask anything. An AI agent that reads every ACHC filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Farley Brian | F | Jul 26, 2026 | 1,770 | $34.51 |
| Farley Brian | F | Jun 26, 2026 | 1,370 | $26.24 |
| Farley Brian | F | Jun 26, 2026 | 1,370 | $26.24 |
| Fucci Michael | A | May 6, 2026 | 6,331 | - |
| WAUD REEVE B | A | May 6, 2026 | 6,331 | - |
| WAUD REEVE B | A | May 6, 2026 | 9,576 | - |
| KELLY RALPH DAVID | A | May 6, 2026 | 6,331 | - |
| Cancelmi Daniel J | A | May 6, 2026 | 6,331 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $2.9B | $3.2B | $3.3B |
| Net Income | -$21.7M | $255.6M | -$1.1B |
| Net Margin | -0.7% | 8.1% | -33.3% |
| Balance Sheet | |||
| Total Assets | $5.4B | $6.0B | $5.5B |
| Equity | $2.8B | $3.1B | $1.9B |
| ROE | -0.8% | 8.3% | -56.6% |
| Per Share | |||
| EPS | - | $2.78 | $-12.16 |
| Cash Flow | |||
| Operating CF | $462.3M | $129.7M | $131.9M |
| CapEx | $424.1M | $690.4M | $571.8M |
Source: XBRL data in Acadia Healthcare Company Inc (ACHC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate ACHC share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 32 | $1.44B |
| Q2 2026 | 33 | $1.68B |
| Q1 2026 | 32 | $1.21B |
| Q4 2025 | 30 | $704.8M |
| Q3 2025 | 29 | $1.08B |
| Q2 2025 | 30 | $938.7M |
| Q1 2025 | 27 | $926.9M |
| Q4 2024 | 24 | $1.13B |
- Goldman Sachs Group+802.3K (+28%)
- Dimensional Fund Advisors+684.7K (+17%)
- Ameriprise Financial+601.1K (+71%)
- Mangrove Partners+522.4K (+37%)
- Invesco Ltd+331.7K (+19%)
- Morgan Stanley−1.98M (-44%)
- Bank of America Corp−347.2K (-47%)
- Citadel Advisors LLC−329.8K (-12%)
- Wells Fargo & Co−256.2K (-87%)
- Principal Financial Group−164.5K (-20%)
- FMR LLC (Fidelity)−5.02M
- Blackstone Group−12.3K
Source: 13F-HR filings on SEC EDGAR (aggregated from 237 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
ACHC filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 10-Q | Nov 4, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Nov 4, 2026 | - | Analysis | - |
| 8-K | Sep 25, 2026 | - | Analysis | - |
| 8-K | Jul 28, 2026 | - | Analysis | - |
| 10-Q | Jul 28, 2026 | Jun 30, 2026 | - | |
| 4 | Jul 27, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 8-K | May 18, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 6, 2026 | - | - | |
| 8-K | May 6, 2026 | - | - | |
| 10-Q | Apr 30, 2026 | Mar 31, 2026 | - | |
| 4 | Apr 30, 2026 | - | - | - |
| 8-K | Apr 29, 2026 | - | - | - |
| 8-K | Apr 23, 2026 | - | - | - |
| 4 | Apr 13, 2026 | - | - | - |
| 4 | Apr 13, 2026 | - | - | - |
Related Health Care companies
- CON · Concentra Group Holdings Parent, Inc.Services-Specialty Outpatient Facilities, NEC
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
- ABSI · Absci CorpServices-Commercial Physical & Biological Research
ACHC SEC filings: frequently asked questions
Which institutions hold ACHC stock?
As of September 30, 2026, the largest Acadia Healthcare Company Inc (ACHC) holders among the 13F filers tracked by SignalX were BlackRock ($407.8 million), Vanguard Portfolio Management LLC ($154.3 million), Dimensional Fund Advisors ($129.2 million), Vanguard Capital Management LLC ($115.9 million), State Street Corp ($105.5 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was ACHC's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Acadia Healthcare Company Inc (ACHC) reported revenue of $3.3 billion (up 5.0% from FY2024) and a net loss of $1.1 billion. Diluted EPS was -$12.16. The figures come from the XBRL data in the 10-K.
What did ACHC report in its latest 8-K?
Acadia Healthcare Company Inc (ACHC) filed an 8-K on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Q3 2026 operating and financial results announced for the quarter ended September 30, 2026.
What are the latest ACHC SEC filings?
Acadia Healthcare Company Inc (ACHC) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on July 27, 2026.
What is ACHC's SEC CIK number?
Acadia Healthcare Company Inc (ACHC)'s SEC Central Index Key (CIK) is 1520697. EDGAR lists every ACHC filing under that number.
Ask anything about ACHC
The research agent reads ACHC's filings, financials, insider trades and 13F holders, then answers with sources.